Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Arachidonate metabolism in vascular disorders.
P W Majerus
P W Majerus
Published November 1, 1983
Citation Information: J Clin Invest. 1983;72(5):1521-1525. https://doi.org/10.1172/JCI111110.
View: Text | PDF
Research Article Article has an altmetric score of 3

Arachidonate metabolism in vascular disorders.

  • Text
  • PDF
Abstract

Authors

P W Majerus

×

Total citations by year

Year: 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2001 2000 1999 1998 1997 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1977 1965 1962 Total
Citations: 1 2 1 2 2 1 4 2 3 6 4 2 9 5 2 3 1 4 5 5 3 3 2 4 2 2 6 5 8 9 10 12 16 26 7 1 1 1 1 183
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (183)

Title and authors Publication Year
Protective effects and potential mechanism of salvianolic acid B on sodium laurate-induced thromboangiitis obliterans in rats
Z Zhang, J Ji, D Zhang, M Ma, L Sun
Phytomedicine : international journal of phytotherapy and phytopharmacology 2020
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines
R Castelli, L Scalvini, F Vacondio, A Lodola, M Anselmi, S Vezzosi, C Carmi, M Bassi, F Ferlenghi, S Rivara, IR Møller, KD Rand, J Daglian, D Wei, EY Dotsey, F Ahmed, KM Jung, N Stella, S Singh, M Mor, D Piomelli
Journal of Medicinal Chemistry 2019
Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs
JM Thomason, AP Mooney, JM Price, JC Whittemore
Frontiers in Veterinary Science 2019
Advances in extracellular ligand recognition sites on prostanoid receptors
Y Li, A Xu, Q Ling, KH Ruan
Future Medicinal Chemistry 2018
Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs
N McLewee, T Archer, R Wills, A Mackin, J Thomason
Journal of Veterinary Pharmacology and Therapeutics 2017
Upper Extremity Deep Venous Thrombosis Prophylaxis After Elective Upper Extremity Surgery
KK Sindhu, B Cohen, T Blood, JA Gil, B Owens
Orthopedics 2017
Textbook of Pediatric Rheumatology
E Silverman, J Buyon, E Jaeggi
Textbook of Pediatric Rheumatology 2016
Omega-3 Fatty Acids
RA Brown
Omega-3 Fatty Acids 2016
Disorders of Thrombosis and Hemostasis in Pregnancy
H Cohen, P O'Brien
2015
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome: Secondary prevention of ACS
S Goto, A Tomita
Clinical Cardiology 2014
Targets and Candidate Agents for Type 2 Diabetes Treatment with Computational Bioinformatics Approach
Q Wang, Z Zhao, J Shang, W Xia
Journal of Diabetes Research 2014
Aspirin may modify tumor microenvironment via antiplatelet effect
BB Su, JH Chen, H Shi, QQ Chen, J Wan
Medical Hypotheses 2014
Anesthetic Pharmacology and Physiology
D Royston
Anesthetic Pharmacology and Physiology 2013
Confirmation of Reported Aspirin Use in Community Studies: Utility of Serum Thromboxane B 2 Measurement
ND Zantek, RV Luepker, S Duval, K Miller, N Oldenburg, AT Hirsch
Clinical and Applied Thrombosis/Hemostasis 2013
Therapeutic Advances in Thrombosis: De Caterina/Therapeutic Advances in Thrombosis
GJ Vlachojannis, V Kunadian, JM Sweeny, R Mehran
Therapeutic Advances in Thrombosis: De Caterina/Therapeutic Advances in Thrombosis 2012
A review of the role of anticoagulation in the treatment of peripheral arterial disease
TF Whayne
International Journal of Angiology 2012
Antiplatelet Drugs
JW Eikelboom, J Hirsh, FA Spencer, TP Baglin, JI Weitz
Chest 2012
Novel Mechanism of the Vascular Protector Prostacyclin: Regulating MicroRNA Expression
A Mohite, A Chillar, SP So, V Cervantes, KH Ruan
Biochemistry 2011
Antiagregantes plaquetarios e inhibidores de la bomba de protones. ¿Cómo optimizar el riesgo-beneficio en los pacientes con riesgo cardiovascular y riesgo de hemorragia gastrointestinal?
R Casado-Arroyo, M Muñoz-Villalenguas, ÁL Arbeloa
Gastroenterología y Hepatología 2011
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
A synthetic prostacyclin agonist, ONO-1301, ameliorates ventricular remodeling after acute myocardial infarction via upregulation of HGF in rat
Y Hirata, T Soeki, H Yamada, A Shiota, M Shimabukuro, Y Sakai, M Nakayama, K Matsumoto, T Igarashi, M Sata
Biomedicine & Aging Pathology 2011
A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury
Y Hirata, M Shimabukuro, E Uematsu, T Soeki, H Yamada, Y Sakai, M Nakayama, K Matsumoto, T Igarashi, M Sata
European Journal of Pharmacology 2011
Endotheliopathy
Y Ouellette, JA Hazelzet
Pediatric Critical Care 2011
Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: Mechanisms of COX-2 inhibitor risk to heart disease
CH Ruan, SP So, KH Ruan
Life Sciences 2010
Aspirin Dosing for the Prevention and Treatment of Ischemic Stroke: An Indication-Specific Review of the Literature
AJ Ansara, SA Nisly, SA Arif, JM Koehler, ST Nordmeyer
The Annals of pharmacotherapy 2010
Antithrombotic therapy: what the dental surgeon has to know
N Kuzniatsova, GY Lip
Faculty Dental Journal 2010
Structural and Functional Analysis of the C-Terminus of Gαq in Complex with the Human Thromboxane A 2 Receptor Provides Evidence of Constitutive Activity
A Chillar, J Wu, V Cervantes, KH Ruan
Biochemistry 2010
Chronic low-dose aspirin therapy attenuates reflex cutaneous vasodilation in middle-aged humans
LA Holowatz, WL Kenney
Journal of applied physiology 2009
Ligand-Specific Conformation Determines Agonist Activation and Antagonist Blockade in Purified Human Thromboxane A2 Receptor
KH Ruan, V Cervantes, J Wu
Biochemistry 2009
Assembling NMR structures for the intracellular loops of the human thromboxane A2 receptor: implication of the G protein-coupling pocket
J Wu, M Feng, KH Ruan
Archives of Biochemistry and Biophysics 2008
Use of antiplatelet agents to prevent stroke: What is the role for combinations of medications?
NE Schwartz, GW Albers
Current Neurology and Neuroscience Reports 2008
An active triple-catalytic hybrid enzyme engineered by linking cyclo-oxygenase isoform-1 to prostacyclin synthase that can constantly biosynthesize prostacyclin, the vascular protector
KH Ruan, SP So, V Cervantes, H Wu, C Wijaya, RR Jentzen
FEBS Journal 2008
Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs
ML Capone, S Tacconelli, LD Francesco, M Petrelli, P Patrignani
Expert Opinion on Drug Safety 2008
Large-scale expression, purification, and characterization of an engineered prostacyclin-synthesizing enzyme with therapeutic potential
KH Ruan, SP So, H Wu, V Cervantes
Archives of Biochemistry and Biophysics 2008
Characterization of the prostaglandin H2 mimic: binding to the purified human thromboxane A2 receptor in solution
KH Ruan, C Wijaya, V Cervantes, J Wu
Archives of Biochemistry and Biophysics 2008
Orofacial Pain and Headache
Y Sharav, R Benoliel
Orofacial Pain and Headache 2008
RETRACTED: Antiplatelet Drugs
C Patrono, C Baigent, J Hirsh, G Roth
Chest 2008
A Simple, Quick, and High-Yield Preparation of the Human Thromboxane A 2 Receptor in Full Size for Structural Studies
KH Ruan, V Cervantes, J Wu
Biochemistry 2008
Is there a role for combinations of antiplatelet agents in stroke prevention?
NE Schwartz, GW Albers
Current Treatment Options in Neurology 2007
Efficacy of Drug Therapy in the Secondary Prevention of Cardiovascular Disease and Stroke
GF Fletcher, V Bufalino, F Costa, LB Goldstein, D Jones, L Smaha, SC Smith, N Stone
The American Journal of Cardiology 2007
Thromboembolic Therapies in Dogs and Cats: An Evidence-Based Approach
KV Lunsford, AJ Mackin
Veterinary Clinics of North America Small Animal Practice 2007
Deep Frying
PC Dutta, R Przybylski, MN Eskin, PL Appelqvist
Deep Frying 2007
Characterization of the Substrate Mimic Bound to Engineered Prostacyclin Synthase in Solution Using High-Resolution NMR Spectroscopy and Mutagenesis: Implication of the Molecular Mechanism in Biosynthesis of Prostacyclin
KH Ruan, J Wu, V Cervantes
Biochemistry 2007
Vascular Medicine
ES Klings, J Loscalzo
Vascular Medicine 2006
Engineering of a Protein with Cyclooxygenase and Prostacyclin Synthase Activities That Converts Arachidonic Acid to Prostacyclin
KH Ruan, H Deng, SP So
Biochemistry 2006
The N-terminal membrane anchor domain of the membrane-bound prostacyclin synthase involved in the substrate presentation of the coupling reaction with cyclooxygenase
KH Ruan, H Deng, J Wu, SP So
Archives of Biochemistry and Biophysics 2005
Solution structure of a common substrate mimetic of cyclooxygenase-downstream synthases bound to an engineered thromboxane A2 synthase using a high-resolution NMR technique
KH Ruan, J Wu, LH Wang
Archives of Biochemistry and Biophysics 2005
Emerging Pathologies in Cardiology
MM Gulizia
2005
Structural and functional characterization of the first intracellular loop of human thromboxane A2 receptor
L Geng, J Wu, SP So, G Huang, KH Ruan
Archives of Biochemistry and Biophysics 2004
Nrf2 Regulates Thromboxane Synthase Gene Expression in Human Lung Cells
M Yaekashiwa, LH Wang
DNA and Cell Biology 2003
Human Endothelial Progenitor Cell-Seeded Hybrid Graft: Proliferative and Antithrombogenic Potentialsin Vitroand Fabrication Processing
T Shirota, H He, H Yasui, T Matsuda
Tissue Engineering 2003
Synergistic effect of D-003 and aspirin on experimental thrombosis models
V Molina, ML Arruzazabala, D Carbajal, R Más
Prostaglandins, Leukotrienes and Essential Fatty Acids 2003
Benefits of Aggressive Drug Therapy:
K Oken, G Fletcher
The Journal of cardiovascular nursing 2003
Clinical Implications of Drug Interactions with Coxibs
WR Garnett
Pharmacotherapy 2001
Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide
K Oketani, T Inoue, M Murakami
European Journal of Pharmacology 2001
Pharmacological control of platelet function
P Clutton, JD Folts, JE Freedman
Pharmacological Research 2001
Platelet-Active Drugs
C Patrono, B Coller, JE Dalen, GA Gerald, V Fuster, M Gent, J Hirsh, G Roth
Chest 2001
Roles of Prostaglandin I 2 and Thromboxane A 2 in Cardiac Ischemia-Reperfusion Injury: A Study Using Mice Lacking Their Respective Receptors
CY Xiao, A Hara, K Yuhki, T Fujino, H Ma, Y Okada, O Takahata, T Yamada, T Murata, S Narumiya, F Ushikubi
Circulation 2001
Platelets
JN George
The Lancet 2000
Identification of Thromboxane Synthase Amino Acid Residues Involved in Heme-Propionate Binding
PY Hsu, AL Tsai, LH Wang
Archives of Biochemistry and Biophysics 2000
Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model
R Doroudi, LM Gan, LS Sjögren, S Jern
Biochemical and Biophysical Research Communications 2000
Identification of the Substrate Interaction Site in the N-terminal Membrane Anchor Segment of Thromboxane A 2 Synthase by Determination of Its Substrate Analog Conformational Changes Using High Resolution NMR Technique
SP So, D Li, KH Ruan
The Journal of biological chemistry 2000
Solution Structure of the Second Extracellular Loop of Human Thromboxane A 2 Receptor
KH Ruan, SP So, J Wu, D Li, A Huang, J Kung
Biochemistry 2000
Endogenous mediators and thrombophilia
JF Martin, RE Smith, A Mathur
Best Practice & Research Clinical Haematology 1999
Expression, Purification, and Spectroscopic Characterization of Human Thromboxane Synthase
PY Hsu, AL Tsai, RJ Kulmacz, LH Wang
The Journal of biological chemistry 1999
Handbook of Platelet Physiology and Pharmacology
GH Rao
1999
Localization and quantification of TXB2 in human healthy and inflammatory gingival mucosa
C Sons-Sicard, A Choquet, R Escola
Journal of Periodontal Research 1998
Oxysterols and TBARS are among the LDL oxidation products which enhance thromboxane A2 synthesis by platelets
MM Mahfouz, FA Kummerow
Prostaglandins & Other Lipid Mediators 1998
Acute Coronary Syndromes: 2. Antiplatelet Agents
DJ Schneider, PB Tracy, BE Sobel
Hospital Practice 1998
Aspirin-induced post-gingivectomy haemorrhage: a timely reminder
JM Thomason, RA Seymour, P Murphy, KM Brigham, P Jones
Journal of Clinical Periodontology 1997
ZD9583, an Orally Effective Thromboxane A2 Synthase Inhibitor and Receptor Antagonist with a Sustained Duration of Action in Rat and Dog
RP Brownlie, NJ Brownrigg, HM Butcher, R Garcia, R Jessup, VJ Lee, S Tunstall, MG Wayne
Journal of Pharmacy and Pharmacology 1997
Induction of cyclooxygenase protein and stimulation of prostaglandin E2 release by epidermal growth factor in cultured guinea pig gastric mucous cells
O Nakano, C Sakamoto, K Matsuda, Y Konda, T Matozaki, H Nishisaki, K Wada, T Suzuki, T Uchida, M Nagao, M Kasuga
Digestive Diseases and Sciences 1995
Synthesis and evaluation of novel fluorinated sulotroban-related sulfonamide derivatives as thromboxane A2 receptor antagonists
M Sato, Y Kawashima, J Goto, Y Yamane, Y Chiba, S Jinno, M Satake, C Iwata
European Journal of Medicinal Chemistry 1995
Aspirin inhibits collagen-induced platelet serotonin release, as measured by microbore high-performance liquid chromatography with electrochemical detection
TH Tsai, WJ Tsai, CF Chen
Journal of Chromatography B Biomedical Sciences and Applications 1995
Aspirin and Other Platelet-Active Drugs
J Hirsh, JE Dalen, V Fuster, LB Harker, C Patrono, G Roth
Chest 1995
Synthesis and evaluation of novel sulfonamide derivatives as thromboxane A2 receptor antagonists I
M Sato, Y Kawashima, J Goto, Y Yamane, Y Chiba, S Jinno, M Satake, C Iwata
European Journal of Medicinal Chemistry 1994
4 Endogenous mediators and thrombophilia
RE Smith, JF Martin
Baillière's Clinical Haematology 1994
Y-20811: A Long-acting Thromboxane A2Synthase Inhibitor
Y Matsumoto, H Mikashima
Cardiovascular Drug Reviews 1993
Clinical Diversity of Raynaud's in Childhood: Report of Six Cases
A Buoncompagni, R Scribanis, P Picco, MD Ricco, P Gandullia, L Baldi, V Pistoia
Lupus 1993
SALT trial
J Gossmann, B Norrving, C Jamieson, SE Smith
The Lancet 1992
Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 6. 4-substituted 3-pyridinylalkanoic acids
SS Bhagwat, C Boswell, C Gude, N Contardo, DS Cohen, J Mathis, R Dotson, W Lee, S Shetty
Bioorganic & Medicinal Chemistry Letters 1992
CGS 22652: A New Potent Thromboxane A2Receptor Antagonist with Selective Thromboxane A2Synthase Inhibitory Properties
DS Cohen, DN McMartin, MP Marietta, PA Zane, RW Lappe
Cardiovascular Drug Reviews 1992
Effects of Y-20811, a thromboxane A2 synthetase inhibitor, on experimentally induced coronary thrombosis in anesthetized dogs
Y Matsumoto, H Ochi, K Aihara, J Inui, K Ikegami
European Journal of Pharmacology 1992
Multiple phospholipase A2 activities in canine vascular smooth muscle
R Miyake, RW Gross
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1992
Effect of prostaglandin E1 on leukotriene C4-induced increases in vascular permeability of hamster cheek pouch
T Yong, WG Mayhan
Inflammation 1992
Overview: New Directions in Inflammatory Bowel Disease Therapy
B Carlson, SN Murthy
Expert Opinion on Therapeutic Patents 1991
Diethylcarbamazine inhibits endothelial and microfilarial prostanoid metabolism in vitro
N Kanesa-thasan, JG Douglas, JW Kazura
Molecular and Biochemical Parasitology 1991
Increased thromboxane production in recalcified challenged whole blood from copper-deficient rats
KG Allen, KJ Lampi, PJ Bostwick, MM Mathias
Nutrition Research 1991
Effect of Low and Ultra Low Oral Doses of Acetylsalicylic Acid in Microvascular Surgery:An Experimental Study in the Rabbit
L Salemark, JB Wieslander, P Dougan, B Arnljots
Journal of Plastic and Reconstructive Surgery and Hand Surgery 1991
Prospect for using eicosapentaenoic and docosahexaenoic acids as drugs (a review)
YF Krylov, IB Lyubimov, AG Mulyar
Pharmaceutical Chemistry Journal 1991
Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction
AG Rebuzzi, A Natale, C Bianchi, E Mariello, E Coppola, G Ciabattoni
European Journal of Clinical Pharmacology 1990
Lipid metabolism and signal transduction in endothelial cells
RE Whatley, GA Zimmerman, TM McIntyre, SM Prescott
Progress in Lipid Research 1990
Influence of transluminal angioplasty on the prostanoid release from the arterial wall
E Mattsson, J Brunkwall, D Bergqvist
European Journal of Vascular Surgery 1990
Kinetic microplate assay for superoxide production by neutrophils and other phagocytic cells
A Rot
Methods in enzymology 1990
G Proteins
J Moss, M Vaughan
G Proteins 1990
10 Lipids and thrombosis
JA Gasser, DJ Betteridge
Baillière's Clinical Endocrinology and Metabolism 1990
Effects of oxysterols on arachidonic acid metabolism and prostacyclin synthesis in bovine aortic smooth muscle cells in culture
C Seilan, C Dubuquoy
Prostaglandins, Leukotrienes and Essential Fatty Acids 1990
Regulation of differentiated properties and proliferation of arterial smooth muscle cells
J Thyberg, U Hedin, M Sjölund, L Palmberg, BA Bottger
Arteriosclerosis (Dallas, Tex.) 1990
Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back
C Patrono
Trends in Pharmacological Sciences 1989
Molecular cardiology: New avenues for the diagnosis and treatment of cardiovascular disease
DR Hathaway, KL March
Journal of the American College of Cardiology 1989
Congenital antithrombin III deficiency: insights into the pathogenesis of the hypercoagulable state and its management using markers of hemostatic system activation
KA Bauer, RD Rosenberg
The American Journal of Medicine 1989
Aspirin and Other Platelet Active Drugs
J Hirsh, EW Salzman, L Harker, V Fuster, JE Dalen, JA Cairns, R Collins
Chest 1989
Carcinogenesis and Dietary Fat
S Abraham
1989
Anesthesia and the Lung
TH Stanley, RJ Sperry
1989
Prädisponierende Bedingungen für akute Ischämiesyndrome
T v. Arnim, A Maseri
1989
Predisposing Conditions for Acute Ischemic Syndromes
T v. Arnim, A Maseri
1989
Evidence of GTP-binding protein regulation of phospholipase A2 activity in isolated human platelet membranes
ST Silk, S Clejan, K Witkom
The Journal of biological chemistry 1989
AN ASPIRIN A DAY FOR UNSTABLE ANGINA?
RA MRCP, RD MRCP
Journal of Clinical Pharmacy and Therapeutics 1988
Prostacyclin and thromboxane A2 formation by atherosclerotic carotid artery: Comparison with normal aorta, saphenous vein, and platelets
DL Akers, MD Kerstein, DS Rush, JA Bellan, DF Haynes, PJ Kadowitz, DB McNamara
Journal of Vascular Surgery 1988
Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, β-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease
E Minar, H Ehringer, M Jung, R Koppensteiner, A Stümpflen
Thrombosis Research 1988
Temperature-dependent skin disorders
EH Page, NH Shear
Journal of the American Academy of Dermatology 1988
Platelets and Antiplatelet Therapy in Ischemic Heart Disease
KP Miller, WH Frishman
Medical Clinics of North America 1988
In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis
K Lauritsen, LS Laursen, K Bukhave, J Rask-Madsen
Gastroenterology 1988
Endothelium from diverse vascular sources synthesizes platelet-activating factor
RE Whatley, GA Zimmerman, TM McIntyre, SM Prescott
Arteriosclerosis (Dallas, Tex.) 1988
Stable prostacyclin analogue preventing microcirculatory derangement in experimental cerebral ischemia in cats
K Tanaka, F Gotoh, Y Fukuuchi, T Amano, N Suzuki, D Uematsu, J Kawamura, T Yamawaki, N Itoh, K Obara
Stroke; a journal of cerebral circulation 1988
Recent Results of Research on Arteriosclerosis
G Schettler
1988
Amaurosis Fugax
EF Bernstein
1988
sn-1,2-Diacylglycerols and phorbol diesters stimulate thromboxane synthesis by de novo synthesis of prostaglandin H synthase in human promyelocytic leukemia cells
M Goerig, AJ Habenicht, R Heitz, W Zeh, H Katus, B Kommerell, R Ziegler, JA Glomset
Journal of Clinical Investigation 1987
Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition
F Gaspari, G Viganò, S Orisio, M Bonati, M Livio, G Remuzzi
Journal of Clinical Investigation 1987
New findings in the fatty acid composition of individual platelet phospholipids in man after dietary fish oil supplementation
TA Mori, JP Codde, R Vandongen, LJ Beilin
Lipids 1987
Tantalus revisited--the search for the ideal anti-thrombotic dose of aspirin
D Deykin, JA Jakubowski, MJ Stampfer, D Faigel
Transactions of the American Clinical and Climatological Association 1987
Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S
RD Rosenberg, KA Bauer
Human Pathology 1987
Estradiol enhances prostaglandin synthase activity in epithelial but not in stromal cells of human endometrium
F Schatz, L Markiewicz, E Gurpide
Journal of Steroid Biochemistry 1987
Apparent specificity of the thrombin-stimulated deacylation of endothelial glycerolipids for polyunsaturated fatty acids with a delta-5 desaturation
MD Rosenthal
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1987
Production of Platelet-activating Factor, a Biologically Active Lipid, by Vascular Endothelial Cells
GA Zimmerman, RE Whatley, TM McIntyre, SM Prescott
American journal of respiratory and critical care medicine 1987
Prostaglandins and Structural Changes in Pulmonary Arteries
M Rabinovitch
American journal of respiratory and critical care medicine 1987
Platelet-inhibitor drugs' role in coronary artery disease
V Fuster, PC Adams, JJ Badimon, JH Chesebro
Progress in Cardiovascular Diseases 1987
Side-Effects of Anti-Inflammatory Drugs
KD Rainsford, GP Velo
1987
Long-Term Management of Patients After Myocardial Infarction
CT Kappagoda, PV Greenwood
1987
Estimated rate of thromboxane secretion into the circulation of normal humans
C Patrono, G Ciabattoni, F Pugliese, A Pierucci, IA Blair, GA FitzGerald
Journal of Clinical Investigation 1986
The role of phosphoinositiees in signal transduction
MC Sekar, LE Hokin
The Journal of Membrane Biology 1986
Cell culture approaches to the analysis of glomerular inflammation
DH Lovett, RB Sterzel
Kidney International 1986
Membrane fluidity and thromboxane synthesis in platelets from patients with severe atherosclerosis
J Moscat, P Perez, FG Gavilanes, F Acin, A Schuller, AM Municio
Thrombosis Research 1986
Aspirin and venous occlusion: Effects on blood fibrinolytic activity and tissue-type plasminogen activator levels
MW Hammouda, LA Moroz
Thrombosis Research 1986
Biochemistry of Platelets
GJ Roth
Biochemistry of Platelets 1986
Gentisic acid: an aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes
A Lorico, P Masturzo, S Villa, M Salmona, N Semeraro, GD Gaetano
Biochemical Pharmacology 1986
Arachidonic acid releasing systems in pig aorta endothelial cells
J Moscat, F Moreno, C Herrero, S Iglesias, P Garcia-Barreno
Biochemical and Biophysical Research Communications 1986
The Effect of Naproxen on Acute Mountain Sickness and Vascular Responses to Hypoxia
RT Meehan, J Hoffman, C Abernathy, S Needleman, A Cymerman, P Rock, CS Fulco, JT Maher
The American Journal of the Medical Sciences 1986
Dose Antiplatelet Agents; The Relationship Among Side Effects, and Antithrombotic Effectiveness
J Hirsh, V Fuster, E Salzman
Chest 1986
Therapeutic opportunities in vasoocclusive disease
JM Ritter, CT Dollery
Circulation 1986
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis
LA Harker
Circulation 1986
Mechanisms of Secondary Brain Damage
A Baethmann, KG Go, A Unterberg
1986
The Metabolism of Phosphoinositide-Derived Messenger Molecules
PW Majerus, TM Connolly, H Deckmyn, TS Ross, TE Bross, H Ishii, VS Bansal, DB Wilson
Science 1986
Platelets and antiplatelet therapy in ischemic heart disease
WH Frishman, K P.Miller
Current Problems in Cardiology 1986
Current Issues in Thrombosis Prevention with Antiplatelet Drugs:
G de Gaetano, C Cerletti, E Dejana, J Vermylen
Drugs 1986
Functionally thrombasthenic state in normal platelets following the administration of ticlopidine
GD Minno, AM Cerbone, PL Mattioli, S Turco, C Iovine, M Mancini
Journal of Clinical Investigation 1985
Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase
AJ Habenicht, M Goerig, J Grulich, D Rothe, R Gronwald, U Loth, G Schettler, B Kommerell, R Ross
Journal of Clinical Investigation 1985
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition
SR Hanson, LA Harker, TD Bjornsson
Journal of Clinical Investigation 1985
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus
C Patrono, G Ciabattoni, G Remuzzi, E Gotti, S Bombardieri, OD Munno, G Tartarelli, GA Cinotti, BM Simonetti, A Pierucci
Journal of Clinical Investigation 1985
Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans
C Schacky, S Fischer, PC Weber
Journal of Clinical Investigation 1985
Eicosanoide und Phospholipasen
M Goerig, AJ Habenicht, G Schettler
Klinische Wochenschrift 1985
Prostaglandins, other eicosanoids and endothelial cells
K Schrör
Basic Research in Cardiology 1985
Zur Bedeutung der Prostaglandine für die in vitro Adhäsivität und die in vivo Margination der neutrophilen Granulozyten
J Fehr, S Bütler
Klinische Wochenschrift 1985
Prostaglandins, thromboxanes and leukotrienes in clinical medicine
RD Zipser, G Laffi
The Western journal of medicine 1985
Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: Dependence on the dose of the aggregating agent
RD Caterina, D Giannessi, P Gazzetti, W Bernini
Thrombosis Research 1985
Effects of aspirin, indomethacin, and sodium salicylate on human erythrocyte membranes as detected with electron spin resonance spectroscopy
DL Mazorow, A Haug, R Bull, EJ McGroarty
Thrombosis Research 1985
Physiologic variables affecting thromboxane B2 production in human whole blood
P Alessandrini, P Avogaro, GB Bon, P Patrignani, C Patrono
Thrombosis Research 1985
Inhibition of human platelet thromboxane generation by aspirin in the absence of measurable drug levels in peripheral blood
C Cerletti, R Latini, E Dejana, G Tognoni, S Garattini, G Gaetano
Biochemical Pharmacology 1985
Endothelial Autacoids
G Thorgeirsson
Acta Medica Scandinavica 1985
Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction
RD Caterina, D Giannessi, W Bernini, P Gazzetti, C Michelassi, A L'abbate, L Donato, P Patrignani, P Filabozzi, C Patrono
The American Journal of Cardiology 1985
Prostaglandin synthesis by the cochlea of the guinea pig. Influence of aspirin, gentamicin, and acoustic stimulation
E Escoubet, P Amsallem, E Ferrary, PT Huy
Prostaglandins 1985
Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease
L Roy, J Mehta, P Mehta
American Heart Journal 1985
Adrenergic stimulation of prostacyclin production in the rat tail artery. I. Response to agonists and antagonists
MS Golub, ME Berger, M Powell
Prostaglandins, Leukotrienes and Medicine 1985
Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction
G de Gaetano, C Cerletti, E Dejana, R Latini
Circulation 1985
Production of platelet-activating factor by human vascular endothelial cells: evidence for a requirement for specific agonists and modulation by prostacyclin
GA Zimmerman, TM McIntyre, SM Prescott
Circulation 1985
Clinical pharmacology of platelet cyclooxygenase inhibition
C Patrono, G Ciabattoni, P Patrignani, F Pugliese, P Filabozzi, F Catella, G Davì, L Forni
Circulation 1985
Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness
J Hirsh
Stroke; a journal of cerebral circulation 1985
Anesthesiology: Today and Tomorrow
TH Stanley, WC Petty
1985
Drugs Affecting Leukotrienes and Other Eicosanoid Pathways
B Samuelsson, F Berti, GC Folco, GP Velo
1985
A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro
C von Schacky, W Siess, S Fischer, PC Weber
Journal of lipid research 1985
Cell cycle-dependent changes in arachidonic acid and glycerol metabolism in Swiss 3T3 cells stimulated by platelet-derived growth factor
AJ Habenicht, JA Glomset, M Goerig, R Gronwald, J Grulich, U Loth, G Schettler
The Journal of biological chemistry 1985
Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels
IF Charo, S Shak, MA Karasek, PM Davison, IM Goldstein
Journal of Clinical Investigation 1984
Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects
JL Mehta, P Mehta, L Lopez, N Ostrowski, E Aguila
Journal of the American College of Cardiology 1984
Low-dose acetylsalicylic acid (100 mg/day) after aortocoronary bypass surgery: a placebo-controlled trial
W Meister, C Schacky, M Weber, R Lorenz, J Kotzur, B Reichart, K Theisen, PC Weber
British Journal of Clinical Pharmacology 1984
Platelets, carotids, and coronaries
ER Eichner
The American Journal of Medicine 1984
Dose-Related Kinetics of Aspirin: Presystemic Acetylation of Platelet Cyclooxygenase
AK Pedersen, GA FitzGerald
New England Journal of Medicine 1984
Inhibition of Platelet Aggregation by Monoclonal Antibody Reactive with β 2 -Microglobulin Chain of HLA Complex
RA Curry, RP Messner, GJ Johnson
Science 1984
The eicosanoids in biology and medicine
AJ Marcus
Journal of lipid research 1984
Aspirin as an Antithrombotic Medication
AJ Marcus
New England Journal of Medicine 1983
Biology of the Uterus
RM Wynn
1977
Advances in Lipid Research
AM Scanu
Advances in Lipid Research 1965
Verhandlungen der Deutschen Gesellschaft für Innere Medizin
B Schlegel
1962

← Previous 1 2 3 … 7 8 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 clinical guideline sources
22 readers on Mendeley
See more details